Dr. David Martin: Humanity Will Prevail but There's a Rough Ride Ahead

I can't say enough about how much I admire Dr David E Martin and his impressive erudition and ability to articulate what is being done to us. The world is only just now beginning to catch up with him and everything he told us in Plandemic II:Show more

“In 2003, the Centers for Disease Control saw the possibility of a gold strike. And that was the coronavirus [SARS-CoV-1] outbreak that happened in Asia. They saw that a virus that they knew could be easily manipulated was something that was very valuable and in 2003, they sought to patent it.

“And they made sure that they controlled the proprietary rights to the disease, to the virus, and to its detection and to the measurement of it.

“We know that Anthony Fauci, that Ralph Baric, that the Centers for Disease Control – and the laundry list of people that wanted to take credit for inventing coronavirus are at the hub of this story.

“From 2003 to 2018, they controlled 100% of the cash flow that built the empire around the industrial complex of coronavirus.

“We know that the manipulation of the coronavirus began with [University of North Carolina Professor of Microbiology and Immunology] Ralph Baric in 1999. Ralph Baric is the researcher at the University of North Carolina-Chapel Hill, who’s famous for his chimeric coronavirus research.

“In 2002, there was a recognition that the coronavirus was seen as an exploitable mechanism for both good and ill. On April 25th, 2003, the US Centers for Disease Control (CDC) filed a patent [US7776521B1], on the coronavirus transmitted to humans.

“Under 35 USC §101, nature is prohibited from being patented. Either SARS coronavirus was manufactured, therefore making a patent on it legal – or it was natural, therefore making a patent on it illegal.

“If it was manufactured, it was a violation of biological and chemical weapons, treaties and laws. If it was natural, filing a patent on it was illegal. In either outcome, both are illegal.

“In the spring of 2007, the CDC filed a petition with the Patent Office to keep their application confidential and private. They actually filed patents not only on the virus, they also filed patents on its detection and a kit to measure it.

“Because of that CDC patent, they had the ability to control who was authorized and who was not authorized to make independent inquiries into coronavirus.

“You cannot look at the virus, you cannot measure it, you cannot develop a test kit for it – and by ultimately receiving the patents that constrain anyone from using it, they had the means, they had the motive and most of all, they had the monetary gain from turning coronavirus from a pathogen to profit.

“Somewhere between 2012 and 2013, something happened. Federal funding for research that was feeding into places like Harvard, Emory, University of North Carolina-Chapel Hill – that funding suddenly became impaired by something that happened at the NIH, where the NIH got this little tiny moment of clarity and said, ‘I think something about what we’re doing is wrong.’

And in 2013, the NIH said gain-of-function research on coronavirus should be suspended.

“The National Institutes of Health had a moral, social and potentially legal reason to object to research but the letters that were sent to the researchers essentially said, ‘you are receiving notice that we’re telling you to stop. And now, on the bottom of the page, we’re going to clarify what ‘stop’ means: ‘keep going.’

“But when the heat gets hot, in 2014 and 2015, what do you do? You offshore the research. You fund the Wuhan Institute of Virology to do the stuff that sounds like it’s getting a little edgy with respect to its morality – but do you do it the straight way? Nah. You run the money [$3.4 million] through a series of cover organizations, to make it look like you’re funding a US operation, which then subcontracts with the Wuhan Institute of Virology.

“The US can say, ‘China did it,’ China could say, ‘The US did it,’ and the cool thing is, both of them are almost telling the truth."